DISC1 a key molecular lead in psychiatry and neurodevelopment: No-More Disrupted-in-Schizophrenia 1

Mol Psychiatry. 2016 Nov;21(11):1488-1489. doi: 10.1038/mp.2016.154. Epub 2016 Sep 6.

Authors

M Niwa¹, T Cash-Padgett¹, K-I Kubo², A Saito¹, K Ishii¹, A Sumitomo³, Y Taniguchi¹, K Ishizuka¹, H Jaaro-Peled¹, T Tomoda³, K Nakajima², A Sawa¹, A Kamiya¹

Affiliations

¹ Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² Department of Anatomy, Keio University School of Medicine, Tokyo, Japan.
³ Medical Innovation Center, Kyoto University, Kyoto, Japan.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Animals, Newborn
Bromodeoxyuridine / metabolism
Cell Proliferation / genetics
Cerebral Cortex* / cytology
Cerebral Cortex* / growth & development
Cerebral Cortex* / metabolism
Embryo, Mammalian
Gene Expression Regulation, Developmental / genetics
Green Fluorescent Proteins / genetics
Green Fluorescent Proteins / metabolism
Humans
Mental Disorders* / genetics
Mental Disorders* / metabolism
Mice
Mice, Transgenic
Nerve Tissue Proteins / genetics
Nerve Tissue Proteins / metabolism*
RNA Interference / physiology
Transfection

Substances

DISC1 protein, human
Nerve Tissue Proteins
Green Fluorescent Proteins
Bromodeoxyuridine

Grants and funding